Equities

Dror Ortho-Design Inc

DROR:PKC

Dror Ortho-Design Inc

Actions
TechnologyTechnology
  • Price (USD)0.009
  • Today's Change0.00 / 0.00%
  • Shares traded63.40k
  • 1 Year change-64.00%
  • Beta-0.4497
Data delayed at least 15 minutes, as of Jul 19 2024 20:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Dror Ortho-Design, Inc. has developed an artificial intelligence (AI)-based platform (the Platform) to correct people's smiles. The Platform uses only one smart aligner to gently move teeth into their optimum position with pulsating air while the patient is sleeping or at home. Its Platform is optimized to correct malocclusions that relate to the social six. Its Platform consists of three primary components: Aerodentis smartphone application, Aerodentis AI Cloud, and the smart aligner system. The Aerodentis smartphone application allows patients to make a video of their smile and teeth and upload the video to the Aerodentis AI Cloud. The Aerodentis AI Cloud is used to perform analytics and manage patient treatment plans. The smart aligner system consists of a base control unit containing the pump and the Internet of Things (IoT) components and a smart aligner containing the micro-balloon that gently pushes teeth into their intended final position using pulsating air.

  • Revenue in USD (TTM)0.00
  • Net income in USD-4.83m
  • Incorporated2001
  • Employees4.00
  • Location
    Dror Ortho-Design Inc480 Johnson Road, Suite 200WASHINGTON 15301United StatesUSA
  • Phone+1 (724) 206-1500
  • Fax+1 (302) 655-5049
  • Websitehttps://www.aerodentis.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Fuse Medical Inc18.40m3.63m3.33m31.001.25--0.90160.18070.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Applied DNA Sciences Inc5.52m-12.50m3.70m53.00------0.6698-17.13-17.137.67-0.05580.389310.384.64104,110.80-87.15-88.57-111.09-121.9133.9844.35-223.89-113.261.54-------26.4327.92-18.73--33.80--
AccuStem Sciences Inc0.00-1.74m3.90m3.00---------0.1537-0.15370.00-0.23090.00----0.00-1,168.46--------------------------45.26------
SINTX Technologies Inc2.78m-8.88m3.94m43.00--0.0138--1.42-389.94-389.9474.21383.240.1381.625.8464,534.88-44.03-45.71-57.11-57.3667.9658.47-318.99-681.801.67--0.0229--68.2994.2449.75--54.10--
Arch Therapeutics Inc130.55k-8.43m4.00m8.00------30.64-3.68-3.680.0425-2.450.08330.0637--16,318.75-538.25-188.28---804.6333.37---6,458.14-26,945.920.0164-1.27----383.83---32.35---21.76--
Venus Concept Inc73.30m-37.39m4.07m304.00------0.0555-6.69-6.6913.12-3.540.74091.062.21241,125.00-37.61-32.71-56.83-44.0168.3768.16-50.77-48.501.35-3.441.40---23.2628.3114.76---35.08--
Encision Inc6.59m-691.78k4.27m22.00--2.34--0.6489-0.0588-0.05880.55950.1541.662.097.27299,357.70-17.41-3.03-24.73-4.1347.6251.25-10.50-1.890.8393-10.270.1272---10.38-5.64-113.55---9.54--
Dror Ortho-Design Inc0.00-4.83m4.46m4.00--1.87-----0.0115-0.01150.000.00480.00-------357.10-140.50-595.21---------118,188.00----0.00-------1,896.02------
Sharps Technology Inc0.00-8.71m4.54m3.00--0.6615-----0.6204-0.62040.000.43780.00-------74.67---95.84----------0.492--0.00-------112.12------
Reflect Scientific Inc1.27m-343.17k4.67m7.00--2.51--3.68-0.004-0.0040.01480.02170.51290.61845.72181,111.40-13.8811.10-16.4313.2156.0662.48-27.0710.002.21--0.00---47.09-6.99-613.46------
ReShape Lifesciences Inc8.34m-10.92m4.73m31.00--1.04--0.5674-2.30-2.300.73190.19330.67810.81784.52268,871.00-88.83-136.06-162.20-194.3265.8556.30-130.99-408.361.26--0.00---22.79-0.947475.36---49.29--
Nu-Med Plus Inc0.00-119.16k4.75m2.00---------0.0014-0.00140.00-0.0020.00----0.00-350.01-447.69---------------22.74--------3.56------
Aethlon Medical, Inc.0.00-12.21m5.11m14.00--0.1676-----4.87-4.870.002.190.00----0.00-94.80-76.25-108.90-85.78-------2,246.87----0.00---100.00---1.43------
Caduceus Software Systems Corp0.00-117.60k5.35m0.00---------0.0004-0.00040.00-0.00040.00-------402.19-11,090.31---------------76.88---------20,519.89------
ADM Tronics Unlimited Inc2.97m-877.23k5.35m7.00--7.73--1.81-0.013-0.0130.04390.01021.134.897.04---33.56-15.22-58.66-22.0937.6541.15-29.58-18.580.8015-316.560.4233---19.35-0.3572-810.74------
Sonendo Inc40.19m-57.74m5.39m216.00--0.2197--0.1341-0.6125-0.55520.4260.34820.44482.077.58186,055.60-63.91---78.82--27.64---143.67--2.14-10.830.4695--5.30---6.78------
Data as of Jul 19 2024. Currency figures normalised to Dror Ortho-Design Inc's reporting currency: US Dollar USD

Institutional shareholders

10.01%Per cent of shares held by top holders
HolderShares% Held
AIGH Capital Management LLCas of 29 Mar 202449.59m10.01%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.